News
a new wearable device for adults with advanced Parkinson’s disease that gives a steady dose of apomorphine under the skin to help manage movement issues and daily symptom changes. Find out the ...
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have announced progress on that front — they have developed a new therapy that uses stem cells to treat advanced Parkinson’s.
For those with more advanced Parkinson’s, tavapadon could be paired with levodopa. "So regardless of when it’s used, whether in the very beginning or as an adjunctive therapy to levodopa, ...
In the early 2000s, a revolution began in Parkinson’s Disease. Animal studies showed ... even in animals with advanced PD. This promise of this data in animals compelled me to leave academia ...
ParkinSINGS, a choir of Parkinson's patients, will sing at the stadium for the second year as part of efforts to raise ...
A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 ...
"It provides patients with another option to alleviate their motor fluctuations that are commonly experienced with levodopa (the best drug we have so far in Parkinson’s) in the moderate to advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results